Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-19 Sale | 2024-08-20 4:27 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 2,321 | $45.12 | $104,727 | 143,222 (Direct) | View |
2024-06-11 Sale | 2024-06-11 7:41 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 2,636 | $31.27 | $82,428 | 145,543 (Direct) | View |
2024-05-16 Sale | 2024-05-17 9:06 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 2,381 | $28.27 | $67,310 | 148,179 (Direct) | View |
2024-03-11 Sale | 2024-03-12 9:58 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 2,615 | $25.65 | $67,082 | 150,560 (Direct) | View |
2024-03-07 Sale | 2024-03-11 9:52 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 9,921 | $25.86 | $256,585 | 153,175 (Direct) | View |
2024-02-28 Sale | 2024-02-28 5:06 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 407 | $25 | $10,175 | 163,096 (Direct) | View |
2024-02-12 Sale | 2024-02-14 4:27 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 5,493 | $25.07 | $137,710 | 163,503 (Direct) | View |
2024-01-26 Sale | 2024-01-26 7:49 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 100 | $25 | $2,500 | 168,996 (Direct) | View |
2023-12-11 Sale | 2023-12-12 5:33 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 2,666 | $10.66 | $28,413 | 169,096 (Direct) | View |
2023-09-12 Sale | 2023-09-13 7:56 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 1,707 | $10.41 | $17,770 | 89,250 (Direct) | View |
2023-06-13 Sale | 2023-06-14 6:40 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 1,698 | $12.43 | $21,106 | 90,957 (Direct) | View |
2023-03-14 Sale | 2023-03-15 5:49 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 7,441 | $13.33 | $99,189 | 92,655 (Direct) | View |
2022-12-12 Sale | 2022-12-13 5:04 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 628 | $10.87 | $6,826 | 156,096 (Direct) | View |
2022-03-11 Sale | 2022-03-14 5:08 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 640 | $8.73 | $5,587 | 66,050 (Direct) | View |
2022-03-02 Sale | 2022-03-03 7:22 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 5,617 | $8.56 | $48,082 | 66,690 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-11-15 Option Award | 2023-11-16 4:29 pm | N/A 2033-11-14 | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 114,643 | $0 | 203,893 (Direct) | View |
2022-12-09 Option Award | 2022-12-13 5:04 pm | N/A 2032-12-08 | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 92,000 | $0 | 156,096 (Direct) | View |
2022-09-15 Disposition | 2022-09-15 5:28 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 658 | $14.05 | 64,724 (Direct) | View |
2022-06-14 Disposition | 2022-06-15 8:03 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 668 | $4.95 | 65,382 (Direct) | View |
2021-12-10 Option Award | 2021-12-14 4:21 pm | N/A 2031-12-09 | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 90,242 | $0 | 140,242 (Direct) | View |
2021-03-02 Option Award | 2021-03-04 7:24 pm | N/A 2031-03-01 | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 300,000 | $0 | 300,000 (Direct) | View |